Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 29:18:e28.
doi: 10.15420/icr.2020.09. eCollection 2023.

Peripartum Cardiogenic Shock and Mechanical Circulatory Support

Affiliations
Review

Peripartum Cardiogenic Shock and Mechanical Circulatory Support

Giulia Botti et al. Interv Cardiol. .

Abstract

Despite remarkable improvements in the past two decades, the annual cardiovascular mortality rate has remained higher for women than for men. Pregnant women represent an underinvestigated population in clinical research, and the mechanisms of long-term cardiovascular complications in women with obstetric complications remain to be elucidated. Regarding advanced heart failure during pregnancy, interventional approaches are effective but still underutilised. Percutaneous mechanical circulatory support is a valuable option for peripartum cardiogenic shock, although its use during pregnancy is still limited. Survival rates have improved in recent years, but further emphasis on the importance of early recognition and initiation of heart failure treatment in this patient group is warranted. The aims of this review are to summarise the current literature on the implementation of mechanical circulatory support in cardiogenic shock during pregnancy and delivery and to understand the role of percutaneous ventricular assist devices in the management of such conditions.

Keywords: Cardiogenic shock; mechanical circulatory support; percutaneous ventricular assist devices (pVAD); pregnancy.

PubMed Disclaimer

Conflict of interest statement

Disclosure: AC has received speaker and consultant fees from Abiomed, Biosensor, Boston Scientific, Medtronic, Menarini and Shock Wave Medical. All other authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Aetiologies of Peripartum Cardiogenic Shock
Figure 2:
Figure 2:. Percutaneous Mechanical Circulatory Support Devices

Similar articles

References

    1. Mann S, Hollier LM, McKay K, Brown H. What we can do about maternal mortality – and how to do it quickly. N Engl J Med. 2018;379:1689–91. doi: 10.1056/NEJMp1810649. - DOI - PubMed
    1. Centers for Disease Control and Prevention. Pregnancy mortality surveillance system. 2023. https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mort... (accessed 27 March 2023)
    1. Berg CJ, Harper MA, Atkinson SM et al. Preventability of pregnancy-related deaths: results of a state-wide review. Obstet Gynecol. 2005;106:1228–34. doi: 10.1097/01.AOG.0000187894.71913.e8. - DOI - PubMed
    1. Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019;364:k5287. doi: 10.1136/BMJ.K5287. - DOI - PubMed
    1. Hameed AB, Lawton ES, McCain CL et al. Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy. Am J Obstet Gynecol. 2015;213(379):e1–10. doi: 10.1016/J.AJOG.2015.05.008. - DOI - PubMed